A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Saved in:
| Title: | A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. |
|---|---|
| Authors: | Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Podoltsev NA; Yale School of Medicine, New Haven, CT, USA. nikolai.podoltsev@yale.edu., Othus M; SWOG Statistics and Data Management Center, Seattle, WA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Rizzieri DA; Duke University Medical Center, Durham, NC, USA., Marcucci G; Ohio State University (Alliance), Columbus, OH, USA.; City of Hope, Duarte, CA, USA., Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Savoie ML; Tom Baker Cancer Centre, Calgary, AB, Canada., Medeiros BC; Stanford University, Stanford, CA, USA., Sekeres MA; Cleveland Clinic, Cleveland, OH, USA.; University of Miami, Maiami, FL, USA., Lin TL; University of Kansas Medical Center, Kansas City, KS, USA., Uy GL; Washington University School of Medicine, St. Louis, USA., Powell BL; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kolitz JE; North Shore University Hospital, Manhasset, NY, USA., Larson RA; University of Chicago, Chicago, IL, USA., Stone RM; Dana Farber Cancer Institute, Boston, MA, USA., Claxton D; Pennsylvania State Milton S Hershey Medical Center, Hummelstown, USA., Essell J; Jewish Hospital, Cincinnati, OH, USA., Luger SM; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Mohan SR; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Moseley A; SWOG Statistics and Data Management Center, Seattle, WA, USA., Appelbaum FR; Fred Hutchinson Cancer Center, Seattle, WA, USA., Erba HP; Duke University Cancer Center, Durham, NC, USA. |
| Source: | Leukemia [Leukemia] 2024 Jan; Vol. 38 (1), pp. 58-66. Date of Electronic Publication: 2023 Nov 07. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37935977 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Podoltsev+NA%22">Podoltsev NA</searchLink>; Yale School of Medicine, New Haven, CT, USA. nikolai.podoltsev@yale.edu.<br /><searchLink fieldCode="AU" term="%22Othus+M%22">Othus M</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Pagel+JM%22">Pagel JM</searchLink>; Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Radich+JP%22">Radich JP</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Fang+M%22">Fang M</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Rizzieri+DA%22">Rizzieri DA</searchLink>; Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Marcucci+G%22">Marcucci G</searchLink>; Ohio State University (Alliance), Columbus, OH, USA.; City of Hope, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Strickland+SA%22">Strickland SA</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Litzow+MR%22">Litzow MR</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Savoie+ML%22">Savoie ML</searchLink>; Tom Baker Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Medeiros+BC%22">Medeiros BC</searchLink>; Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sekeres+MA%22">Sekeres MA</searchLink>; Cleveland Clinic, Cleveland, OH, USA.; University of Miami, Maiami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Lin+TL%22">Lin TL</searchLink>; University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Uy+GL%22">Uy GL</searchLink>; Washington University School of Medicine, St. Louis, USA.<br /><searchLink fieldCode="AU" term="%22Powell+BL%22">Powell BL</searchLink>; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kolitz+JE%22">Kolitz JE</searchLink>; North Shore University Hospital, Manhasset, NY, USA.<br /><searchLink fieldCode="AU" term="%22Larson+RA%22">Larson RA</searchLink>; University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Claxton+D%22">Claxton D</searchLink>; Pennsylvania State Milton S Hershey Medical Center, Hummelstown, USA.<br /><searchLink fieldCode="AU" term="%22Essell+J%22">Essell J</searchLink>; Jewish Hospital, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Luger+SM%22">Luger SM</searchLink>; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mohan+SR%22">Mohan SR</searchLink>; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Moseley+A%22">Moseley A</searchLink>; SWOG Statistics and Data Management Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Appelbaum+FR%22">Appelbaum FR</searchLink>; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Erba+HP%22">Erba HP</searchLink>; Duke University Cancer Center, Durham, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2024 Jan; Vol. 38 (1), pp. 58-66. <i>Date of Electronic Publication: </i>2023 Nov 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37935977 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-023-02073-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 58 Titles: – TitleFull: A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Garcia-Manero G – PersonEntity: Name: NameFull: Podoltsev NA – PersonEntity: Name: NameFull: Othus M – PersonEntity: Name: NameFull: Pagel JM – PersonEntity: Name: NameFull: Radich JP – PersonEntity: Name: NameFull: Fang M – PersonEntity: Name: NameFull: Rizzieri DA – PersonEntity: Name: NameFull: Marcucci G – PersonEntity: Name: NameFull: Strickland SA – PersonEntity: Name: NameFull: Litzow MR – PersonEntity: Name: NameFull: Savoie ML – PersonEntity: Name: NameFull: Medeiros BC – PersonEntity: Name: NameFull: Sekeres MA – PersonEntity: Name: NameFull: Lin TL – PersonEntity: Name: NameFull: Uy GL – PersonEntity: Name: NameFull: Powell BL – PersonEntity: Name: NameFull: Kolitz JE – PersonEntity: Name: NameFull: Larson RA – PersonEntity: Name: NameFull: Stone RM – PersonEntity: Name: NameFull: Claxton D – PersonEntity: Name: NameFull: Essell J – PersonEntity: Name: NameFull: Luger SM – PersonEntity: Name: NameFull: Mohan SR – PersonEntity: Name: NameFull: Moseley A – PersonEntity: Name: NameFull: Appelbaum FR – PersonEntity: Name: NameFull: Erba HP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Jan Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 38 – Type: issue Value: 1 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |